title: Evaluation of oxime efficacy in nerve agent poisoning: development of a kinetic-based dynamic model.
abstract: The widespread use of organophosphorus compounds (OP) as pesticides and the repeated misuse of highly toxic OP as chemical warfare agents (nerve agents) emphasize the necessity for the development of effective medical countermeasures. Standard treatment with atropine and the established acetylcholinesterase (AChE) reactivators, obidoxime and pralidoxime, is considered to be ineffective with certain nerve agents due to low oxime effectiveness. From obvious ethical reasons only animal experiments can be used to evaluate new oximes as nerve agent antidotes. However, the extrapolation of data from animal to humans is hampered by marked species differences. Since reactivation of OP-inhibited AChE is considered to be the main mechanism of action of oximes, human erythrocyte AChE can be exploited to test the efficacy of new oximes. By combining enzyme kinetics (inhibition, reactivation, aging) with OP toxicokinetics and oxime pharmacokinetics a dynamic in vitro model was developed which allows the calculation of AChE activities at different scenarios. This model was validated with data from pesticide-poisoned patients and simulations were performed for intravenous and percutaneous nerve agent exposure and intramuscular oxime treatment using published data. The model presented may serve as a tool for defining effective oxime concentrations and for optimizing oxime treatment. In addition, this model can be useful for the development of meaningful therapeutic animal models.
authors.affiliation: Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstrasse 11, 80937 Munich, Germany. FranzWorek@Bundeswehr.org
authors.forename: Franz
authors.initials: F
authors.lastname: Worek
authors.forename: Ladislaus
authors.initials: L
authors.lastname: Szinicz
authors.forename: Peter
authors.initials: P
authors.lastname: Eyer
authors.forename: Horst
authors.initials: H
authors.lastname: Thiermann
mesh_terms: D000109:Acetylcholine / Q000378:metabolism; D000465:Algorithms; D000818:Animals; D002619:Chemical Warfare Agents / Q000378:metabolism / Q000506:poisoning*; D002800:Cholinesterase Inhibitors / Q000378:metabolism / Q000506:poisoning; D002801:Cholinesterase Reactivators / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics; D004305:Dose-Response Relationship, Drug; D006168:Guinea Pigs; D006801:Humans; D007700:Kinetics; D008875:Middle Aged; D008954:Models, Biological; D010091:Oximes / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics; D015203:Reproducibility of Results; D013997:Time Factors
chemical_list: D002619:Chemical Warfare Agents; D002800:Cholinesterase Inhibitors; D002801:Cholinesterase Reactivators; D010091:Oximes; D000109:Acetylcholine